Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy

NCT00228969 is registered in ClinicalTrials.gov with SK Life Science, Inc. as lead sponsor.

NCT NCT00228969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00228969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy
Lead sponsor
SK Life Science, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
May 31, 2006
Enrollment
Not reported
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

refractory epilepsy